Literature DB >> 16364276

Postprandial lipemic response and lipoprotein composition in subjects with low or high cholesterol absorption efficiency.

Jyrki J Agren1, Maarit Hallikainen, Helvi Vidgren, Tatu A Miettinen, Helena Gylling.   

Abstract

BACKGROUND: The purpose of this study was to investigate the effect of differences in cholesterol absorption efficiency on the postprandial lipemia and lipoprotein composition.
METHODS: Fifteen healthy subjects were divided into low and high cholesterol absorbers on the basis of serum cholestanol to cholesterol ratio. A high-performance liquid chromatographic method with evaporative light scattering detection was developed for quantitation of free and esterified cholesterol, triglycerides and major phospholipids from the same lipid extract in two runs utilizing the same internal standard.
RESULTS: The free cholesterol to phosphatidylcholine ratio of chylomicrons was higher in the high cholesterol absorption group. The total increase of cholesterol in combined chylomicron and very low density lipoprotein (VLDL) fraction was also higher in this group. Chylomicron free cholesterol and cholesterol ester responses correlated with fasting low density lipoprotein (LDL) cholesterol. VLDL and VLDL1 triglyceride responses correlated inversely with fasting insulin and homeostasis model assessment of insulin resistance.
CONCLUSIONS: High cholesterol absorption efficiency was seen in chylomicrons as higher cholesterol to phosphatidylcholine ratio during the postprandial peak. Chylomicron cholesterol response was linked to fasting LDL cholesterol and low VLDL triglyceride response to fasting insulin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364276     DOI: 10.1016/j.cca.2005.11.006

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Postprandial lipemia in the elderly involves increased incorporation of ingested fat in plasma free fatty acids and small (Sf 20-400) triglyceride-rich lipoproteins.

Authors:  Guilherme M Puga; Christian Meyer; Sarah Everman; Lawrence J Mandarino; Christos S Katsanos
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

2.  Lipidomic profiling of chylomicron triacylglycerols in response to high fat meals.

Authors:  Maxine P Bonham; Kaisa M Linderborg; Aimee Dordevic; Amy E Larsen; Kay Nguo; Jacquelyn M Weir; Petra Gran; Marika K Luotonen; Peter J Meikle; David Cameron-Smith; Heikki P T Kallio; Andrew J Sinclair
Journal:  Lipids       Date:  2012-11-03       Impact factor: 1.880

3.  Postprandial lipid responses to an alpha-linolenic acid-rich oil, olive oil and butter in women: a randomized crossover trial.

Authors:  Julia Svensson; Anna Rosenquist; Lena Ohlsson
Journal:  Lipids Health Dis       Date:  2011-06-28       Impact factor: 3.876

4.  Physical activity and sedentary behaviour in relation to cardiometabolic risk in children: cross-sectional findings from the Physical Activity and Nutrition in Children (PANIC) Study.

Authors:  Juuso Väistö; Aino-Maija Eloranta; Anna Viitasalo; Tuomo Tompuri; Niina Lintu; Panu Karjalainen; Eeva-Kaarina Lampinen; Jyrki Ågren; David E Laaksonen; Hanna-Maaria Lakka; Virpi Lindi; Timo A Lakka
Journal:  Int J Behav Nutr Phys Act       Date:  2014-04-26       Impact factor: 6.457

5.  Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study.

Authors:  Ursula Schwab; Tuulikki Seppänen-Laakso; Laxman Yetukuri; Jyrki Agren; Marjukka Kolehmainen; David E Laaksonen; Anna-Liisa Ruskeepää; Helena Gylling; Matti Uusitupa; Matej Oresic
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

6.  Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial.

Authors:  Hayley L Loftus; Katie J Astell; Michael L Mathai; Xiao Q Su
Journal:  Nutrients       Date:  2015-11-17       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.